Macy's profit and sales slip impacting profit forecast for 2025

The retail giant saw a dip in its sales during the first quarter as it grapples with tariffs and consumers cutting back on spending.

Southwest Airlines’ baggage fee, other policies changing this week

Southwest Airlines has made major changes to its policies in recent months, with almost all of them going into effect Wednesday. Here’s what to know.

Bags don't fly free anymore; Southwest abandons long-standing perk

It's the end of an airline industry mainstay: Southwest Airlines had touted its no-baggage fees for decades. But all of that is coming to an end. 

Pepsi knocked out of America's top selling soft drinks

Many Americans already have strong opinions on the Coca-Cola vs. Pepsi debate, and now another soft drink has entered the chat.

These companies expect to raise their prices due to Trump tariffs

Some of the biggest retailers have announced increases on the price of their products to offset tariff costs. Here’s what we know.

Memorial Day 2025: What’s open, closed

The vast majority of retailers will be open, with many trying to lure customers with big promotional sales.

Here’s how much a made-in-America iPhone could cost

President Trump’s threat to impose a 25% tariff on Apple unless it manufactures iPhones in the U.S. could send prices soaring, with estimates reaching as high as $3,500 per device.

High chairs sold on Amazon recalled for fall and entrapment risk

The Consumer Product Safety Commission has recalled more than 5,000 Boyro Baby 4-in-1 convertible high chairs sold on Amazon due to serious safety hazards.

Target's sales drop in Q1, and they may continue dropping all year

Target's sales fell more than the Minneapolis-based retailer expected they would in the first quarter, and the company is warning they will slip for the rest of the year as shoppers limit spending.

Nearly half of Gen Z admits to lying on job applications, survey finds

New survey data indicates that one in four job applicants has lied, exaggerated or provided inaccurate information on their applications in some way, shape or form — and Gen Z leads the trend.

23andMe acquired by biotech giant Regeneron after bankruptcy filing

Biotechnology leader Regeneron Pharmaceuticals is acquiring genetic testing firm 23andMe for $256 million following its bankruptcy filing. The deal excludes 23andMe’s telehealth subsidiary, Lemonaid Health.